In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

The U.S. government has signed health deals with at least nine African countries, part of its new approach to global health ...

Medicaid programs made more than $200 million in improper payments to healthcare providers between 2021 and 2022 for people ...

Arizona/Utah: The large outbreak on the Arizona-Utah border continues to grow, with 190 cases in Arizona (14 new cases) and ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...

The public's views of measles, mumps, and rubella (MMR) vaccine safety and effectiveness have dropped, as has willingness to ...

Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...

The FDA has expanded the indication of ferric maltol (Accrufer) capsules for the treatment of iron deficiency to include ...

At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether ...

Science Signaling retracted a 2017 paper that linked a specific amyloid form (amyloid-beta 56) to tau pathology after an ...

Starting an incretin receptor agonist -- especially tirzepatide (Mounjaro, Zepbound) -- was associated with reduced risks of ...